{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:12:13Z","timestamp":1786633933738,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The University of Texas Health Science Center"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI104960"],"award-info":[{"award-number":["AI104960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Tech University Health Sciences Center El Paso"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tube.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T11:22:08Z","timestamp":1556191328000},"page":"S28-S33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S","title":["Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)"],"prefix":"10.1016","volume":"116","author":[{"given":"XiuZhen","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Files","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice J.","family":"Endsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Endsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.04.008_bib1","series-title":"2017 global tuberculosis Report","author":"WHO","year":"2018"},{"issue":"3","key":"10.1016\/j.tube.2019.04.008_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-119-3-199308010-00003","article-title":"Risk for developing tuberculosis among anergic patients infected with HIV","volume":"119","author":"Moreno","year":"1993","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tube.2019.04.008_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082235","article-title":"Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis","volume":"9","author":"Mesfin","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tube.2019.04.008_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119332","article-title":"Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors","volume":"10","author":"Chung-Delgado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.04.008_bib5","series-title":"C.f.D. Control, Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin","first-page":"921","year":"1996"},{"issue":"2","key":"10.1016\/j.tube.2019.04.008_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkw463","article-title":"Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis","volume":"72","author":"Boerma","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.tube.2019.04.008_bib7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/jit107","article-title":"Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings","volume":"207","author":"Hosseinipour","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2019.04.008_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, Bayluscide","volume":"19","author":"Andrews","year":"1982","journal-title":"Pharmacol Ther"},{"issue":"27","key":"10.1016\/j.tube.2019.04.008_bib9","doi-asserted-by":"crossref","first-page":"42126","DOI":"10.18632\/oncotarget.9704","article-title":"Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt\/beta-catenin signaling","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.tube.2019.04.008_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3892\/ijmm.2016.2689","article-title":"Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family","volume":"38","author":"Suliman","year":"2016","journal-title":"Int J Mol Med"},{"issue":"15","key":"10.1016\/j.tube.2019.04.008_bib11","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/1078-0432.CCR-12-2895","article-title":"Anticancer effects of niclosamide in human glioblastoma","volume":"19","author":"Wieland","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.tube.2019.04.008_bib12","doi-asserted-by":"crossref","first-page":"e74670","DOI":"10.1371\/journal.pone.0074670","article-title":"Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.tube.2019.04.008_bib13","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","article-title":"The anti-helminthic niclosamide inhibits Wnt\/Frizzled 1 signaling","volume":"48","author":"Chen","year":"2009","journal-title":"Biochemistry"},{"issue":"13","key":"10.1016\/j.tube.2019.04.008_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pros.23015","article-title":"Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition","volume":"75","author":"Liu","year":"2015","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.tube.2019.04.008_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029290","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/beta-catenin pathway","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tube.2019.04.008_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1535-7163.MCT-12-0002","article-title":"Growth inhibition of ovarian tumor-initiating cells by niclosamide","volume":"11","author":"Yo","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"10.1016\/j.tube.2019.04.008_bib17","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1016\/j.bmc.2009.05.054","article-title":"Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.tube.2019.04.008_bib18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.tube.2019.04.008_bib19","doi-asserted-by":"crossref","first-page":"e0124595","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.tube.2019.04.008_bib20","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.48.7.2693-2696.2004","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide","volume":"48","author":"Wu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.tube.2019.04.008_bib21","doi-asserted-by":"crossref","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2019.04.008_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2016.10.003","article-title":"Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission","volume":"135","author":"Wang","year":"2016","journal-title":"Antivir Res"},{"issue":"10","key":"10.1016\/j.tube.2019.04.008_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.tube.2019.04.008_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1054\/tuld.1999.0212","article-title":"Antituberculosis activity of certain antifungal and antihelmintic drugs","volume":"79","author":"Sun","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2019.04.008_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3389\/fmicb.2018.02417","article-title":"Novel screen to assess bactericidal activity of compounds against non-replicating Mycobacterium abscessus","volume":"9","author":"Berube","year":"2018","journal-title":"Front Microbiol"},{"issue":"4828","key":"10.1016\/j.tube.2019.04.008_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.3313729","article-title":"Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line","volume":"238","author":"Folks","year":"1987","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.tube.2019.04.008_bib27","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"issue":"Suppl","key":"10.1016\/j.tube.2019.04.008_bib28","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S1472-9792(13)70013-1","article-title":"In vitro model of mycobacteria and HIV-1 co-infection for drug discovery","volume":"93","author":"Vijayakumar","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"issue":"11","key":"10.1016\/j.tube.2019.04.008_bib29","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1128\/JVI.00006-13","article-title":"A novel PCR assay for quantification of HIV-1 RNA","volume":"87","author":"Shan","year":"2013","journal-title":"J Virol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219301477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979219301477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:43:23Z","timestamp":1761468203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979219301477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"alternative-id":["S1472979219301477"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.04.008","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}